IL5 and asthma: In murine studies, the absence of IL-5 in deficient animals or the blockade of IL-5 with monoclonal antibodies led to improved symptoms of ovalbumin- or HDM-induced asthma, including airway remodeling, airway hyperresponsiveness and mucus production by airway epithelial cells [83, 84].